TAVR Now: Changing How We Treat Aortic Valve Disease

Wednesday, May 22, 2019: 12:15 PM-1:15 PM
Castellana Ballroom 2 (The Cosmopolitan of Las Vegas)

Supported By: Edwards Lifesciences

Sponsored By:

This satellite symposium will use a combination of literature review and case-based presentations to offer a critical review of the available data on TAVR in low surgical risk patients with severe symptomatic aortic stenosis. A preview of upcoming data and a discussion of specific considerations related to this patient subset will be included.
Moderator:
Chad Kliger, M.D., FSCAI
12:15 PM
Welcome and Introductions
Chad Kliger, M.D., FSCAI, Lenox Hill Heart and Vascular Institute of New York
12:17 PM
TAVR Hemodynamics Post-implantation: Is ECHO Enough?
Amr E Abbas md, M.D., FSCAI, William Beaumont Hospital
12:29 PM
Understanding the Low-Risk TAVR Trials and How They Affect Your Valve Program
Philippe Genereux MD, M.D., Atlantic Health
12:41 PM
Improving TAVR Efficiencies from Diagnosis to Discharge: Identifying Aortic Stenosis and 3M Integration
Chandan Devireddy, M.D., FSCAI, Emory University
12:53 PM
Shared Decision-Making: What is it Really?
Megan Coylewright, M.D., FSCAI, Dartmouth-Hitchcock Medical Center
1:05 PM
Panel Discussion and Audience Q & A
See more of: Satellite Sessions
<< Previous Satellite | Next Satellite >>